All Work

Jon C. Ogg

Is Mallinckrodt Running Out of Options?

Mallinckrodt is a pharmaceutical player that has been in trouble over its role in the opioid crisis in America. Investors have to wonder if the worst outcome is in the making.

Jon C. Ogg · 7 years ago